Evidence map›Paper›PMID 34196877›Full record

Observational studyClinical and experimental nephrology2021

Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19.

Gaetano Alfano, Annachiara Ferrari, Francesco Fontana, Giacomo Mori, Riccardo Magistroni, Marianna Meschiari, Erica Franceschini, Marianna Menozzi, Gianluca Cuomo, Gabriella Orlando and 13 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Clinical and experimental nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Electronic Phenotype for Detection, Staging, and Subtyping of Acute Kidney Injury.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. The relation between proteinuria and the severity of COVID-19.Clinical and experimental nephrology · 2024
    Article
  9. Outcome Comparison in Hospitalized COVID-19 Patients With and Without AKI.Journal of community hospital internal medicine perspectives · 2024
    Article
  10. [Severe post-COVID-19 dialysis dependence and inpatient acute kidney injury].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Observational
  11. Article
  12. Article
  13. Review
  14. Acute Kidney Injury Among Admitted COVID-19 Patients in Addis Ababa, Ethiopia.International journal of nephrology and renovascular disease · 2023
    Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 1 institution in 1 country.

Gaetano AlfanoNephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy. gaetano.alfano@unimore.it.ORCID http://orcid.org/0000-0003-0591-8622
Annachiara FerrariSurgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.
Francesco FontanaNephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.
Giacomo MoriNephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.
Riccardo MagistroniNephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.
Marianna MeschiariDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Erica FranceschiniDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Marianna MenozziDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Gianluca CuomoDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Gabriella OrlandoDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Antonella SantoroDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Margherita DigaetanoDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Cinzia PuzzolanteDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Federica CarliDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Andrea BediniDepartment of Infectious Diseases, University Hospital of Modena, Modena, Italy.
Jovana MilicClinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
Irene ColorettiDepartment of Anesthesia and Intensive Care Unit, University Hospital of Modena, Modena, Italy.
Paolo RaggiDepartment of Medicine, Division of Cardiology, Mazankowski Alberta Heart Institute, Alberta, Canada.
Cristina MussiniSurgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.
Massimo GirardisDepartment of Anesthesia and Intensive Care Unit, University Hospital of Modena, Modena, Italy.
Gianni CappelliNephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy.
Giovanni GuaraldiSurgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.
Modena Covid-19 Working Group (MoCo19)
University of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) is a severe complication of coronavirus disease-2019 (COVID-19). This study aims to evaluate incidence, risk factors and case-fatality rate of AKI in patients with COVID-19.

methodsWe reviewed the health medical records of 307 consecutive patients with COVID-19 hospitalized at the University Hospital of Modena, Italy.

resultsAKI was diagnosed in 69 out of 307 (22.4%) COVID-19 patients. Stages 1, 2, or 3 AKI accounted for 57.9%, 24.6% and 17.3%, respectively. AKI patients had a mean age of 74.7 ± 9.9 years. These patients showed higher serum levels of the main markers of inflammation and higher rate of severe pneumonia than non-AKI patients. Kidney injury was associated with a higher rate of urinary abnormalities including proteinuria (0.44 ± 0.85 vs 0.18 ± 0.29 mg/mg; P =  < 0.0001) and microscopic hematuria (P = 0.032) compared to non-AKI patients. Hemodialysis was performed in 7.2% of the subjects and 33.3% of the survivors did not recover kidney function after AKI. Risk factors for kidney injury were age, male sex, CKD and higher non-renal SOFA score. Patients with AKI had a mortality rate of 56.5%. Adjusted Cox regression analysis revealed that COVID-19-associated AKI was independently associated with in-hospital death (hazard ratio [HR] = 4.82; CI 95%, 1.36-17.08) compared to non-AKI patients.

conclusionAKI was a common and harmful consequence of COVID-19. It manifested with urinary abnormalities (proteinuria, microscopic hematuria) and conferred an increased risk for death. Given the well-known short-term sequelae of AKI, prevention of kidney injury is imperative in this vulnerable cohort of patients.

Indexed as

Acute Kidney InjuryAgedAged, 80 and overCOVID-19FemaleHematuriaHumansIncidenceItalyMaleMiddle AgedPrognosisProteinuriaRetrospective StudiesRisk AssessmentRisk FactorsAKICOVID-19DialysisMortalityRisk factorsUrine

Identifiers

PMID34196877
PMCPMC8245663
OpenAlexW3175444772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.